2. Van Den Brule AJ, Walboomers JM, Du Maine M, et al: Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 1991; 48(3): 404-408

3. Koutsky LA, Holmes KK, Critchlow CW, et al: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327: 1272-1278

4. Mitchell H, Drake M, Medley G: Prospective evaluation of risk of cervical cancer after cytological evidence of human papilloma virus infection. Lancet 1986; 1: 573-575

5. Campion MJ, McCance DJ, Cuzick J, et al: Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet 1986; 2: 237-240

6. Pagano R, Chanen W, Rome RM, et al: The significance of human papilloma virus atypia ('wart virus infection') found alone on cervical cytology screening. Aust N Z J Obstet Gynaecol 1987; 27(2): 136-139

7. Ritter DB, Kadish AS, Vermund SH, et al: Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population. Am J Obstet Gynecol 1988; 159(6): 1517-1525

8. Reeves WC, Brinton LA, Garcia M, et al: Human papillomavirus infection and cervical cancer in Latin America. New Engl J Med 1989; 320(22): 1437-1441

9. Borst M, Butterworth CE, Baker V, et al: Human papillomavirus screening for women with atypical Papanicolaou smears. J Reprod Med 1991; 36(2): 95-99

10. Rader JS, Rosenzweig BA, Spirtas R, et al: Atypical squamous cells. A case-series study of the association between papanicolaou smear results and human papillomavirus DNA genotype. J Reprod Med 1991; 36(4): 291-297

11. Schiffman MH, Bauer HM, Hoover RN, et al: Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Nat Cancer Inst 1993; 85: 958-964

12. Meisels A, Morin C: Human papillomavirus and cancer of the uterine cervix. Gynecol Oncol 1981; 12(2 Pt 2): S111-S123

13. Syrjanen K, Vayrynen M, Saarikoski S, et al: Natural history of cervical human papillomavirus (HPV) infections based on prospective follow-up. Br J Obstet Gynecol 1985; 92: 1086-1092

14. Carmichael JA, Maskens PD: Cervical dysplasia and human papillomavirus. Am J Obstet Gynecol 1989; 160: 916-918

15. Koutsky, LA, Galloway DA, Holmes KK: Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988; 10: 122-163

16. Schiffman MH: Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Nat Cancer Inst 1992; 84(6) 394-398

17. Reeves WC, Rawls WE, Brinton LA: Epidemiology of genital papillomaviruses and cervical cancer. Rev Infect Dis 1989; II(3): 426-439

18. Kitchener HC, Neilson L, Burnett RA, et al: Prospective serial study of viral change in the cervix and correlation with human papillomavirus genome status. Br J Obstet Gynecol 1991; 98(10): 1042-1048

19. Schneider A, Meinhardt G, de Villiers E-M, et al: Sensitivity of the cytologic diagnosis of cervical condyloma in comparison with HPV DNA hybridization studies. Diagn Cytopathol 1987; 3: 250-255

20. Spitzer M, Brandsma JL, Steinberg B, et al: Detection of conditions related to human papillomavirus. Comparison of cytology, colposcopy, histology, and hybridization. J Reprod Med 1990; 35(7): 697-703

21. Reid R, Greenberg MD, Lorincz A, et al: Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection? Am J Obstet Gynecol 1991; 164: 1461-1471

22. Cecchini S, Iossa A, Grazzini G: Estimate of clinical human papillomavirus infection prevalence in a population-based screening. Cervix Lower Fem Genit Tract 1988; 6(3): 213-217

23. de Villiers E-M: Laboratory techniques in the investigation of human papillomavirus infection. Genitourin Med 1992; 68: 50-54

24. Wilbur DC, Stoler MH: Testing for human papillomavirus: basic pathobiology of infection, methodologies, and implications for clinical use. Yale J Biol Med 1991; 64: 113-125

25. Yliskoski M, Saarikoski S, Syrjanen K: Conization for CIN associated with human papillomavirus infection. Arch Gynecol Obstet 1991; 249(2): 59-65

26. Kirby P, Dunne A, King DH, et al: Double-blind randomized clinical trial of self-administered podofilox solution versus vehicle in the treatment of genital warts. Am J Med 1990; 88: 465-469

27. Eron LJ, Judson F, Tucker S, et al: Interferon therapy for condylomata acuminata. N Engl J Med 1986; 315: 1059-1064

28. Yliskoski M, Cantell K, Syrjanen K, et al: Topical treatment with human leukocyte interferon of HPV 16 infections associated with cervical and vaginal intraepithelial neoplasias. Gynecol Oncol 1990; 36(3): 353-7

29. Dunham AM, McCartney JC, McCance DJ, et al: Effect of perilesional injection of alpha-interferon on cervical intraepithelial neoplasia and associated human papillomavirus infection. J R Soc Med 1990; 83(8): 490-492

30. Ferenczy A, Mitao M, Nagai N, et al: Latent papillomavirus and recurring genital warts. N Engl J Med 1985; 313: 784-788

31. Riva JM, Sedlacek TV, Cunnane MF, et al: Extended carbon dioxide laser vaporization in the treatment of subclinical papillomavirus infection of the lower genital tract. Obstet Gynecol 1989; 73: 25-30

32. Shafi MI, Finn C, Luesley DM, et al: Carbon dioxide laser treatment for vulval papillomatosis (vulvodynia). Br J Obstet Gynaecol 1990; 97(12): 1148-1150

33. Ruge S, Felding C, Skouby SO, et al: CO2-laser vaporization of human papillomavirus (HPV)-induced abnormal cervical smears. A simple and effective solution to a recurrent clinical problem. Clin Exp Obstet Gynecol 1991; 18(2): 99-101